Clavijo Raul I, Kohn Taylor P, Kohn Jaden R, Ramasamy Ranjith
Department of Urology, University of California, Los Angeles, CA, USA.
Baylor College of Medicine, Houston, TX, USA.
J Sex Med. 2017 Jan;14(1):27-35. doi: 10.1016/j.jsxm.2016.11.001. Epub 2016 Dec 13.
Low-intensity extracorporeal shock wave therapy (Li-ESWT) has been proposed as an effective non-invasive treatment option for erectile dysfunction (ED).
To use systematic review and meta-analysis to assess the efficacy of Li-ESWT by comparing change in erectile function as assessed by the erectile function domain of the International Index of Erectile Function (IIEF-EF) in men undergoing Li-ESWT vs sham therapy for the treatment of ED.
Systematic search was conducted of MEDLINE, EMBASE, and ClinicalTrials.gov for randomized controlled trials that were published in peer-reviewed journals or presented in abstract form of Li-ESWT used for the treatment of ED from January 2010 through March 2016. Randomized controlled trials were eligible for inclusion if they were published in the peer-reviewed literature and assessed erectile function outcomes using the IIEF-EF score. Estimates were pooled using random-effects meta-analysis.
Change in IIEF-EF score after treatment with Li-ESWT in patients treated with active treatment vs sham Li-ESWT probes.
Data were extracted from seven trials involving 602 participants. The average age was 60.7 years and the average follow-up was 19.8 weeks. There was a statistically significant improvement in pooled change in IIEF-EF score from baseline to follow-up in men undergoing Li-ESWT vs those undergoing sham therapy (6.40 points; 95% CI = 1.78-11.02; I = 98.7%; P < .0001 vs 1.65 points; 95% CI = 0.92-2.39; I = 64.6%; P < .0001; between-group difference, P = .047). Significant between-group differences were found for total treatment shocks received by patients (P < .0001).
In this meta-analysis of seven randomized controlled trials, treatment of ED with Li-ESWT resulted in a significant increase in IIEF-EF scores.
低强度体外冲击波疗法(Li-ESWT)已被提议作为勃起功能障碍(ED)的一种有效的非侵入性治疗选择。
通过系统评价和荟萃分析,比较接受Li-ESWT治疗与假治疗的男性勃起功能障碍患者勃起功能的变化,以评估Li-ESWT的疗效,勃起功能通过国际勃起功能指数(IIEF-EF)的勃起功能领域进行评估。
对MEDLINE、EMBASE和ClinicalTrials.gov进行系统检索,以查找2010年1月至2016年3月发表在同行评审期刊或以摘要形式呈现的用于治疗ED的Li-ESWT的随机对照试验。如果随机对照试验发表在同行评审文献中并使用IIEF-EF评分评估勃起功能结果,则符合纳入标准。使用随机效应荟萃分析汇总估计值。
接受积极治疗的患者与接受假Li-ESWT探头治疗的患者在接受Li-ESWT治疗后IIEF-EF评分的变化。
数据来自7项试验,涉及602名参与者。平均年龄为60.7岁,平均随访时间为19.8周。接受Li-ESWT治疗的男性与接受假治疗的男性相比,从基线到随访的IIEF-EF评分合并变化有统计学显著改善(6.40分;95%CI=1.78-11.02;I=98.7%;P<.0001,而假治疗组为1.65分;95%CI=0.92-2.39;I=64.6%;P<.0001;组间差异,P=.047)。患者接受的总治疗冲击次数存在显著组间差异(P<.0001)。
在这项对7项随机对照试验的荟萃分析中,Li-ESWT治疗ED导致IIEF-EF评分显著增加。